Jamie L. Wagner

Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification

John S. Esterly, Jamie L. Wagner, Milena M. McLaughlin et al. · Antimicrobial Agents and Chemotherapy · 2012 · 83 citations · Full text

Drug Resistance, Susceptibility Breakpoint, Antimicrobial Stewardship +21

Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections

Michael P. Veve, Jamie L. Wagner, Rachel M. Kenney et al. · International Journal of Antimicrobial Agents · 2016 · 49 citations

Urology, Antimicrobial Susceptibility, Health Sciences +9

Surgical prophylaxis with gram‐negative activity for reduction of surgical site infections after microvascular reconstruction for head and neck cancer

Jamie L. Wagner, Rachel M. Kenney, José A. Vázquez et al. · Head & Neck · 2016 · 20 citations

Impact of an antifungal stewardship intervention on optimization of candidemia management

Hana Rac, Jamie L. Wagner, S. Travis King et al. · Therapeutic Advances in Infectious Disease · 2017 · 19 citations · Full text

Impact of Obesity on Acyclovir-Induced Nephrotoxicity

Katie E. Barber, Jamie L. Wagner, Kayla R. Stover · Open Forum Infectious Diseases · 2019 · 19 citations · Full text